41/236/2026 -Medicamento Fibrinogénio humano 1000 mg Pó sol inj Fr IV e Lanreotida 120 mg/488 mg Sol inj Ser 0.5

ID 12704727 · Portal BASE
Price
Base Price
€43,309 .00
Effective Price
€43,309 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33690000
Location
Portugal, Faro, Faro
Bidder Count
—
Winners
OCTAPHARMA-PRODUTOS FARMACÊUTICOS LDA
NIF 502820780
Company
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
Dates
Publication
20 Jan 2026
Celebration
13 Nov 2025
Contracting Entity
Centro Hospitalar Universitário do Algarve, EPE
NIF 510745997
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
20 Jan 2026
Signing Date
13 Nov 2025
Days Late
68
Rule
A2/A3 late publication: 68 days after signing (threshold: 10)
Detected 2026-03-06